Stephane Louvrier

Chief Revenue & Strategy Officer & Co-Founder, OKOsix | Healthcare Ecosystem & Health Insurance Executive | Former Cigna / Groupama / Now Health | APAC & Europe | Health Innovation, Provider Networks & Transformation

📍 Hong Kong🔄 Updated September 2026💼 1 investments📅 6 years investing🗓 Last invested Apr 2020
Operator-angel🌍 Hong Kong
1
Total investments
0
Early stage
0
Mid stage
0
Late stage
6y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Apr 2020
✅ Thanks to our solution you will be able to better understand and anticipate your customers​ payment behaviour and the risk of default on outstanding payments. 👉Your decision making for the management of your receivables portfolio can therefore be optimized. 👉Its management will become much more dynamic. 👉You will be ready for a proactive approach to collection and will be able to measure the impact of your decisions on the evolution of your cash flow / receivables portfolio. Our solution calculates and logs a set of risk and performance indicators. In addition to the DSO and the average payment time, our solution provides specific indicators such as a payment profile or a level of risk related to outstanding receivables. Aividens also makes it possible to assess the risk of default of each invoice in accordance with the new IFRS9 standards. Awards: 
 🏆 Credit Management Innovation Award 2023 - IVKM 🏆 Innovation Award 2023 - AFDCC
Experience · 4 entries
All (4)
Investments (1)
Founder (3)
2023
Co-founder & Chief Revenue & Strategy Officer
Jun 2023
OKOsix was founded to set new standards for planet-friendly disposable products and advance a sustainable circular economy. We tackle plastic pollution at its source by developing plant-based alternatives to fossil-fuel plastics. With OKOmer, we source FROM NATURE to create raw materials that run seamlessly on existing production lines. These materials are used in medical masks, gowns, cosmetic facial masks, wipes, and moldable applications such as diagnostic tests. OKOmer products can be disposed of as ordinary waste — no complex recycling required — as they fully biodegrade and return TO NATURE. For durable applications, OKOplastics offers 100% recyclable, low-carbon bioplastics made from renewable feedstocks, suitable for packaging, automotive components, consumer goods, and electronics. As a pioneer in green plastics, OKOsix is recognized by Global Market Insights as the innovator behind the world’s first medical-grade biodegradable face mask. Our patent-pending technology has received the Gold Award at the International Exhibition of Inventions of Geneva (2022), and the Healthcare Innovation and Technology Award from the World Institute of Sustainable Development Planners. OKOsix also stands out in global startup competitions including TechCrunch Disrupt Startup Battlefield 2025 (Global Top 200), SWITCH Slingshot 2025 (Global Top 60), and EPIC 2025 Best Pitcher Award.
2020
Investor
Apr 2020
✅ Thanks to our solution you will be able to better understand and anticipate your customers​ payment behaviour and the risk of default on outstanding payments. 👉Your decision making for the management of your receivables portfolio can therefore be optimized. 👉Its management will become much more dynamic. 👉You will be ready for a proactive approach to collection and will be able to measure the impact of your decisions on the evolution of your cash flow / receivables portfolio. Our solution calculates and logs a set of risk and performance indicators. In addition to the DSO and the average payment time, our solution provides specific indicators such as a payment profile or a level of risk related to outstanding receivables. Aividens also makes it possible to assess the risk of default of each invoice in accordance with the new IFRS9 standards. Awards: 
 🏆 Credit Management Innovation Award 2023 - IVKM 🏆 Innovation Award 2023 - AFDCC
2006
EURO ASIA BUSINESS DEVELOPMENT ASSOCIATES
Co-Founder & Managing Partner
Jun 2006
Co-Founder
Jun 2006
Hexilis is a premier boutique consultancy specialising in driving high-impact digital and operational transformation across the Insurance, Healthcare, and Financial Services sectors. With over 19 years of global experience, we act as a strategic bridge between multifaceted business challenges and state-of-the-art technological solutions. We are a team of multi-skilled executive consultants (former Heads of Business Development, Sales Directors, and Data Science leads) who combine deep domain expertise with a hands-on approach to execution. From our headquarters in Hong Kong and our EMEA presence, we have a proven track record of generating measurable ROI in highly regulated, competitive markets. At Hexilis, we dont just advise; we execute. Our work has moved underperforming markets from an IRR of -5% to +18%, increased claims automation from 20% to 80%, and reduced medical underwriting times by 40%. Whether it is negotiating a complex market entry in China or deploying sophisticated Speech Analytics across APAC, we ensure your strategic vision translates into enterprise-wide adoption. Our Core Capabilities: * AI & InsurTech Transformation • Global Change & Stakeholder Leadership • Data Strategy & Predictive Analytics • Distribution Channel Management (Agency, Broker, Direct, Digital, & Bancassurance) • Customer Experience (CX) & Service Quality Optimisation • Operational Performance & Six Sigma Process Improvement • Contact Centre & Sales Agent Optimisation • Financial Risk, Fraud, & Compliance Management • Market Entry Strategy & International Partnerships • Cost Containment, TPA Network Development, & Medical Tourism We partner with global health insurance companies, BPO providers, and emerging Tech firms to accelerate business outcomes through the intelligent application of Generative AI, Data Science, and Lean Operational principles.